Myriad Genetics restores most systems after unauthorized access disrupts testing operations
MYGN•Myriad Genetics temporarily suspended testing and order management after detecting unauthorized network access on November 2. Most systems have returned to normal, and the company does not expect a material adverse impact while it investigates whether patient records were accessed.
1. Systems mostly restored
Myriad Genetics temporarily suspended testing operations and order management systems after detecting unauthorized network access on November 2, 2026. Most systems have returned to normal operations, and the company does not expect a material adverse impact; an investigation is assessing the scope of access, including whether patient records were accessed.
